Chinese electric-car maker Li Auto and pharmaceutical company WuXi Apptec will join the Hang Seng Index as new constituents next month, according to the latest quarterly review by Hong Kong’s ...

FDA-approved T-cell cancer therapy (a technology pioneered in Philadelphia), and name-brand research products. WuXi AppTec said the sale covered its U.S. and U.K. Advanced Therapies facilities.

Founded in 2001 as WuXi PharmaTech, the company rebranded to its current name after acquiring the U.S.-based AppTec Laboratory Services in 2008. Long Wei—Feature China/Future Publishing/Getty Images ...

Shares in WuXi Biologics and WuXi AppTec have tracked up after the BIOSECURE Act – which could have profound effects on their businesses in the US – was omitted from legislation due to be ...